AmpliPhi Biosciences Corp Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Companys securities registered under Section 12 of the Exchange Act
AmpliPhi Biosciences Corp
Biotechnology
2024
Letter Agreement, dated July 10, 2023, by and between the Company and Deborah Birx
AmpliPhi Biosciences Corp
Biotechnology
WA
2023
Description of the Companys securities registered under Section 12 of the Exchange Act
AmpliPhi Biosciences Corp
Biotechnology
2023
Letter Agreement, dated December 14, 2022, by and between Armata Pharmaceuticals, Inc. and Todd R. Patrick
AmpliPhi Biosciences Corp
Biotechnology
CA
2022
Description of the Companys securities registered under Section 12 of the Exchange Act
AmpliPhi Biosciences Corp
Biotechnology
2022
Description of the Companys securities registered under Section 12 of the Exchange Act
AmpliPhi Biosciences Corp
Biotechnology
2021
Letter Agreement, dated as of March 10, 2020, by and between Armata Pharmaceuticals, Inc. and the Cystic Fibrosis Foundation
AmpliPhi Biosciences Corp
Biotechnology
WA
2020
Description of the Companys securities registered under Section 12 of the Exchange Act
AmpliPhi Biosciences Corp
Biotechnology
2020
Form of Director Appointment Letter
AmpliPhi Biosciences Corp
Biotechnology
WA
2019
Engagement letter agreement, dated December 13, 2017, as amended on December 17, 2018, by and between the Company and Ladenburg Thalmann & Co. Inc
AmpliPhi Biosciences Corp
Biotechnology
FL
2019
Form of C3J Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein
AmpliPhi Biosciences Corp
Biotechnology
2019
Form of Company Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein
AmpliPhi Biosciences Corp
Biotechnology
2019
Form of C3J Therapeutics Support Agreement, dated January 3, 2019, by and between the Company and each of the parties named in each agreement therein
AmpliPhi Biosciences Corp
Biotechnology
WA
2019
Form of Company Support Agreement, dated January 3, 2019, by and between C3J Therapeutics and each of the parties named in each agreement therein
AmpliPhi Biosciences Corp
Biotechnology
WA
2019
AMPLIPHIBIOSCIENCES CORPORATION COMMONSTOCK ISSUANCE AGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
NY
2016
ASSET PURCHASEAGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
CA
2016
DATED 4th November 2015 (“AgreementDate”)
AmpliPhi Biosciences Corp
Biotechnology
2016
US: 4870 Sadler Rd. Suite 300, Glen Allen, VA23060 AU: Unit 7 27 Dale Street, Brookvale 2100 NSW
AmpliPhi Biosciences Corp
Biotechnology
2016
TABLE OF CONTENTS
AmpliPhi Biosciences Corp
Biotechnology
2014
Schedule 1 Relevant PatentApplications
AmpliPhi Biosciences Corp
Biotechnology
2014
AMENDMENT NO. 4 TO EXCLUSIVE SUBLICENSE AGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
2009
AMENDED AND RESTATED MANUFACTURING AGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
CA
2009
The Childrens Hospital of Philadelphia Joseph Stokes, Jr., Research Institute Department of Sponsored Projects 3615 Civic Center Blvd. ARC 142 Philadelphia, PA 19104-4318 Phone...
AmpliPhi Biosciences Corp
Biotechnology
2006
Description of Document
AmpliPhi Biosciences Corp
Biotechnology
2006
Current assets
AmpliPhi Biosciences Corp
Biotechnology
WA
2004
Legal Proceedings
AmpliPhi Biosciences Corp
Biotechnology
2004
FINANCIAL INFORMATION
AmpliPhi Biosciences Corp
Biotechnology
2003
EXHIBIT10.42 TO
AmpliPhi Biosciences Corp
Biotechnology
2003
EXHIBIT10.41 TO
AmpliPhi Biosciences Corp
Biotechnology
2003
TARGETED GENETICS CORPORATION THIRD AMENDMENT TO RIGHTS AGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
2003
TARGETED GENETICS CORPORATION SECOND AMENDMENT TO RIGHTS AGREEMENT
AmpliPhi Biosciences Corp
Biotechnology
2002